A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
Clinical trial NCT04630145 · COMPLETED
Trial details
- NCT number
- NCT04630145
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-08
- Primary completion
- 2024-11-06
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.